University of Missouri scientists assisting Missouri officials with Coronavirus Sewershed Surveillance Project
On Jun. 23, 2020, studies in the Netherlands and other places have shown that the presence of SARS-Coronavirus-2,…
INOVIO received $71 million contract from U.S. Dept of Defense to scale up manufacture of CELLECTRA 3PSP smart device
On Jun. 23, 2020, INOVIO announced it had received $71 million funding from the U.S. Department of Defense…
COVID-19 | Diagnostics | NIH
PathGroup selected as partner for launch of Illumina’s sequencing-nased COVID-19 diagnostic test
On Jun. 23, 2020, PathGroup announced the award of a funding grant from the National Institutes of Health…
Catalent partnered with ViralClear Pharmaceuticals on potential treatment for COVID-19
On Jun. 22, 2020, Catalent announced that it had signed an agreement with ViralClear Pharmaceuticals, a subsidiary of…
Taconic Biosciences announced distribution of critical COVID-19 mouse model
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
The NIH halted clinical trial of hydroxychloroquine
On Jun. 20, 2020, the National Institutes of Health (NIH) announced that a clinical trial to evaluate the…
GSK COVID-19 vaccine development collaboration with Clover Biopharmaceuticals began clinical trials
On Jun. 19, 2020, GSK announced that a scientific collaboration with Clover Pharmaceuticals to develop an adjuvanted COVID-19…
Dynavax announced first participants dosed in phase 1 clinical trial evaluating Clover Biopharma’s COVID-19 S-Trimer vaccine candidate with CpG 1018 adjuvant
On Jun. 19, 2020, Dynavax Technologies announced the first participants were dosed in the Phase 1 clinical trial…
COVID-19 Pandemic dramatically increased out-of-hospital cardiac arrest cases and deaths in New York City
On Jun. 19, 2020, the COVID-19 pandemic in New York City caused a surge in out-of-hospital cardiac arrests…
Tonix Pharma and Southern Research announced expansion of COVID-19 vaccine collaboration
On Jun. 18, 2020, Tonix Pharmaceuticals announced an expansion of its strategic collaboration with Southern Research to include…
The FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator
On Jun. 18, 2020, the FDA announced participation in the COVID-19 Diagnostics Evidence Accelerator, a multi-stakeholder collaborative project…
Oxford University and Bvlgari announced collaboration to fight COVID-19 and future pandemics
On Jun. 17, 2020, Bvlgari, the Italian luxury brand, announced plans to support research into COVID-19 and vaccine…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
Innovation Pharma’s Brilacidin inhibited SARS-CoV-2 by 97 percent in a human lung cell line
On Jun. 17, 2020, Innovation Pharma reported receiving data from ongoing laboratory testing being conducted at a U.S….
Aclaris Therapeutics supported investigator-initiated clinical trial of ATI-450 for cytokine release syndrome in hospitalized COVID-19 patients
On Jun. 17, 2020, Aclaris Therapeutics announced that the FDA had allowed an investigational new drug application to…
The FDA revoked Emergency Use Authorization for Chembio antibody test
On Jun. 16, 2020, the FDA revoked the emergency use authorization (EUA) of the Chembio Diagnostic System DPP…
All of Us Research Program launched COVID-19 research initiatives
On Jun. 16, 2020, the All of Us Research Program, part of the National Institutes of Health, announced…
Low-cost dexamethasone reduced death by up to one third in hospitalised patients with severe respiratory complications of COVID-19
On Jun. 16, 2020, the University of Oxford reported that overall dexamethasone reduced the 28-day mortality rate by…
San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19
On Jun. 16, 2020, a consortium that includes many of San Diego’s top medical and scientific research institutes…
NanoString announced new products to advance COVID-19 disease research
On Jun. 16, 2020, NanoString Technologies announced the availability of new solutions to study the immune response in…
Biotechnology | COVID-19 | Therapeutics | WHO
WHO announced preliminary results about dexamethasone use in treating critically ill COVID-19 patients
On Jun. 16, 2020, the World Health Organization (WHO) announced that initial clinical trial results from the United…
Super-potent human antibodies protect against COVID-19 in animal tests
On Jun. 15, 2020, a team led by Scripps Research discovered antibodies in the blood of recovered COVID-19…
Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….
Lilly begans phase 3 clinical trial with baricitinib for hospitalized COVID-19 patients
On Jun. 15, 2020, Eli Lilly announced that the first patient has been enrolled in a Phase 3…
Catalent announced agreement with AstraZeneca to manufacture COVID-19 vaccine candidate
On Jun. 15, 2020, Catalent announced that it will provide vial filling and packaging capacity to AstraZeneca at…
Immunic announced first patients dosed in its phase 2, CALVID-1 clinical trial of IMU-838 in COVID-19
On Jun. 15, 2020, Immunic announced dosing of the first patients in its phase 2, CALVID-1 clinical trial…
Cleveland Clinic researchers developed first model to predict likelihood of testing positive for COVID-19 and outcomes from the disease
On Jun. 15, 2020, Cleveland Clinic researchers announced they had developed the worldﾒs first risk prediction model for…
The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…
The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…
NIH launched analytics platform to harness nationwide COVID-19 patient data to speed treatments
On Jun. 15, 2020, the NIH announced it had launched a centralized, secure enclave to store and study…